Predictors of disease activity in patients with clinically isolated syndrome (CIS) treated with interferon β 1b in the BENEFIT trial

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2013
This article has no abstract
Epistemonikos ID: 7a81f0ee3586362fbc6911203b37486297f5f54a
First added on: Apr 30, 2026